AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) Updates FY17 Earnings Guidance
AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) updated its FY17 earnings guidance on Thursday. The company provided earnings per share guidance of $5.85-5.92 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.86. The company issued revenue guidance of +5% to ~$154.2 billion, compared to the consensus revenue estimate of $155.12 billion.
A number of equities research analysts have recently commented on the stock. Bank of America Corporation cut shares of AmerisourceBergen Corporation (Holding Co) from a buy rating to a neutral rating and reduced their target price for the company from $95.76 to $94.00 in a research report on Friday, June 30th. UBS AG reduced their target price on shares of AmerisourceBergen Corporation (Holding Co) from $94.00 to $87.00 and set a neutral rating for the company in a research report on Friday. Zacks Investment Research upgraded shares of AmerisourceBergen Corporation (Holding Co) from a sell rating to a hold rating in a research report on Friday. Vetr cut shares of AmerisourceBergen Corporation (Holding Co) from a buy rating to a hold rating and set a $90.84 target price for the company. in a research report on Thursday, April 6th. Finally, Jefferies Group LLC reiterated a hold rating and issued a $95.00 target price on shares of AmerisourceBergen Corporation (Holding Co) in a research report on Wednesday, June 21st. Seven analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. AmerisourceBergen Corporation (Holding Co) currently has a consensus rating of Buy and a consensus price target of $93.64.
Shares of AmerisourceBergen Corporation (NYSE:ABC) traded down 1.08% on Friday, reaching $80.83. 2,882,893 shares of the company’s stock traded hands. AmerisourceBergen Corporation has a 52 week low of $68.38 and a 52 week high of $97.85. The stock has a market capitalization of $17.65 billion, a price-to-earnings ratio of 15.69 and a beta of 0.91. The stock’s 50-day moving average price is $93.75 and its 200-day moving average price is $89.47.
AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) last issued its quarterly earnings data on Thursday, August 3rd. The company reported $1.43 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.37 by $0.06. AmerisourceBergen Corporation (Holding Co) had a return on equity of 60.21% and a net margin of 0.77%. The business had revenue of $38.71 billion for the quarter, compared to the consensus estimate of $39.13 billion. During the same period last year, the business earned $1.37 EPS. The firm’s revenue was up 4.9% compared to the same quarter last year. Equities analysts predict that AmerisourceBergen Corporation will post $5.87 EPS for the current year.
In related news, Chairman Steven H. Collis sold 15,000 shares of the firm’s stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $94.76, for a total value of $1,421,400.00. Following the transaction, the chairman now directly owns 253,876 shares of the company’s stock, valued at approximately $24,057,289.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 27.40% of the stock is currently owned by company insiders.
ILLEGAL ACTIVITY WARNING: This piece of content was reported by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/04/amerisourcebergen-corporation-holding-co-nyseabc-updates-fy17-earnings-guidance.html.
AmerisourceBergen Corporation (Holding Co) Company Profile
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Receive News & Ratings for AmerisourceBergen Corporation (Holding Co) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen Corporation (Holding Co) and related companies with MarketBeat.com's FREE daily email newsletter.